In this context, it is worth mentioning that ALT-positive cancer cells are more sensitive than telomerase-positive cancer cells to trabectedin, an anti-tumor drug that causes R-loop-dependent DNA damage and leads to replication impairment and genome instability [49,50]. This evidence concerns the gene GPT and cancer.